Danske Bank Extends CS MEDICA's Credit Line

Danske Bank has extended its 1,2 million DKK credit line to CS MEDICA.

CS MEDICA, a global MedTech company specializing in CBD and pain management, announces that Danske Bank, Denmark's foremost financial institution, has extended its extraordinary credit facility of 1,2 million DKK to CS MEDICA to 31st January 2024. 

For more information about CS MEDICA, please contact:
Gitte Lund Henriksen, CFO
Phone: + (45) 2774 2280
Email: glh@cs-medica.com
Website: https://www.cs-medica.com/

CS MEDICA is a Danish-based MedTech company operating within research, development, manufacturing, commercializing, and operating within the pharmaceutical industry. The company combines science and nature with the purpose of creating over-the-counter treatments to fight autoimmune and stress-related diseases, built upon our knowledge of the endocannabinoid system, patients' needs, and our experience in the pharmaceutical industry. We do so by pioneering scientific breakthroughs, expanding access to our treatments, understanding patients globally, and working to prevent the pain caused by the diseases we treat.

The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information, visit cs-medica.com and LinkedIn.

Tags: